4-(Difluoromethoxy)aniline

We are 4-(Difluoromethoxy)aniline CAS:22236-10-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(Difluoromethoxy)aniline
CAS.NO:22236-10-8
Synonyms:4-(Difluoromethoxy)aniline
α,α-Difluoro-p-anisidine
4-difluoromethoxyphenylamine
Molecular Formula:C7H7F2NO
Molecular Weight:159.13300
 
Physical and Chemical Properties:
Density:1.283
Boiling point:231ºC
Flash point:>230°F
Index of Refraction:1.505
 
Specification:
Appearance:Dark brown clear liquid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

4-(Difluoromethoxy)aniline


Related News: Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates.6,7-Dimethoxy-3,4-dihydroquinazoline-4-one CAS:13794-72-4 These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.1-chloro-10-iododecane At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.376591-94-5 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.

Related Products
Product Name
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine View Details
1-Cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole View Details
9H-Purine-2,6-diamine, 9-.β.-D-ribofuranosyl- View Details
N2-phenylacetyl-L-glutamine manufacturer Octachlorocyclopentene manufacturer N-butyl-N-methylpyrrolidinium bis(trifluoromethyl manufacturer 5-Ethyl-2-[2-(4-nitrophenoxy)ethyl]pyridine manufacturer 2-Phenoxyethylamine manufacturer